ProAssurance Corporation Announces Dates for Fourth Quarter Earnings Release and Conference Call

GlobeNewswire

  
BIRMINGHAM, AL - January 21, 2014 -- ProAssurance Corporation (PRA) will report results for the fourth quarter of 2013 after the close of normal New York Stock Exchange trading on Thursday, February 20, 2014.

ProAssurance will conduct a conference call at 10:00 am ET on Friday, February 21, 2014 to discuss the results and other topics of interest to investors.  Investors are invited to participate by phone by dialing (888) 556-4997 (toll free) or (719) 325-2495.  The conference call will also be webcast on Streetevents.com, and through the Investor Relations section of ProAssurance.com.

A telephone replay of the call will be available through March 7, 2014 at (888) 203-1112 (toll free) or (719) 457-0820, using access code 7891659.  A replay will be available on the internet through March 21, 2014 at ProAssurance.com and Streetevents.com.  ProAssurance will make a podcast of the call available on its website and on iTunes.

About ProAssurance
ProAssurance (www.ProAssurance.com) is an industry-leading specialty insurance company with extensive expertise in medical professional liability, products liability for medical technology and life sciences and legal professional liability. ProAssurance is recognized as one of the top performing insurance companies in America by virtue of its inclusion in the Ward`s 50 for the past seven years. ProAssurance is rated "A+" (Superior) by A.M. Best and rated "A" (Strong) by Fitch Ratings.

Contact:

Frank B. O`Neil
Sr. Vice President, Corporate Communications & Investor Relations
800-282-6242
205-877-4461
foneil@ProAssurance.com




This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: ProAssurance Corporation via GlobeNewswire

HUG#1756212
View Comments (0)